Barriers to generating PDX models of HPV-related head and neck cancer

被引:30
|
作者
Facompre, Nicole D. [1 ]
Sahu, Varun [1 ]
Montone, Kathleen T. [1 ,2 ]
Harmeyer, Kayla M. [1 ]
Nakagawa, Hiroshi [3 ]
Rustgi, Anil K. [3 ]
Weinstein, Gregory S. [1 ]
Gimotty, Phyllis A. [4 ]
Basu, Devraj [1 ,5 ,6 ]
机构
[1] Univ Penn, Dept Otorhinolaryngol Head & Neck Surg, 3400 Spruce St,5 Ravdin Silverstein, Philadelphia, PA 19104 USA
[2] Univ Penn, Dept Pathol, Philadelphia, PA 19104 USA
[3] Univ Penn, Dept Med, Philadelphia, PA 19104 USA
[4] Univ Penn, Dept Biostat & Epidemiol, Philadelphia, PA 19104 USA
[5] Philadelphia VA Med Ctr, Philadelphia, PA USA
[6] Wistar Inst Anat & Biol, 3601 Spruce St, Philadelphia, PA 19104 USA
来源
LARYNGOSCOPE | 2017年 / 127卷 / 12期
关键词
Patient-derived xenograft; HPV; head and neck cancer; preclinical model; SQUAMOUS-CELL CARCINOMA; PAPILLOMAVIRUS-POSITIVE HEAD; PATIENT-DERIVED XENOGRAFTS; HUMAN-MALIGNANT TUMOR; OROPHARYNGEAL CANCER; LUNG-CANCER; NUDE-MICE; IMMUNODEFICIENT MICE; EPITHELIAL-CELLS; ROCK INHIBITOR;
D O I
10.1002/lary.26679
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Objectives/HypothesisDelineate factors impacting the creation and use of patient-derived xenografts (PDXs) of human papilloma virus-related (HPV+) head and neck squamous cell carcinomas (HNSCCs). Study DesignLaboratory-based translational study. MethodsFifty-one surgically resected HNSCCs, including 31 HPV+cancers, were implanted into NOD/SCID/IL-2R(-/-) (NSG) mice using standardized methodology. Clinical and pathologic factors were tested for association with engraftment. The gross, histologic, and molecular features of established HPV+PDXs were analyzed in comparison to their tumors of origin. ResultsNegative HPV status and perineural invasion (PNI) were independent, additive factors associated with increased PDX formation. Epstein-Barr virus-positive (EBV+) human large B-cell lymphomas grew from 32% of HPV+HNSCC cases that failed to engraft. Successfully established HPV+PDXs retained basaloid histology and often developed cystic growth patterns typical of HPV+nodal metastases. They also maintained elevated p16(INK4A) levels and expression of E6/E7 viral oncogene transcripts. ConclusionReduced engraftment by HPV+tumors lacking PNI likely results in selection biases in HNSCC PDX models. Formation of EBV+lymphomas in NSG mice further reduces the generation of HPV+models and must be ruled out before long-term use of PDXs. Nevertheless, the retention of distinctive pathologic traits and viral oncogene expression by HPV+PDXs provides a viable in vivo platform for basic and translational studies as well as a resource for generating advanced in vitro models. Level of EvidenceNA. Laryngoscope, 127:2777-2783, 2017
引用
收藏
页码:2777 / 2783
页数:7
相关论文
共 50 条
  • [31] Differential disruption of the Rb pathway in HPV-related head and neck carcinomas
    Begum, S
    Gillison, ML
    Westra, WH
    MODERN PATHOLOGY, 2005, 18 : 211A - 211A
  • [32] Current trends in the etiology and diagnosis of HPV-related head and neck cancers
    Chai, Ryan C.
    Lambie, Duncan
    Verma, Mukesh
    Punyadeera, Chamindie
    CANCER MEDICINE, 2015, 4 (04): : 596 - 607
  • [33] Quality of Life and Psychosocial Factors in Post-Treatment HPV-Related Head and Neck Cancer
    Hartlein, Taylor E.
    Thielhelm, Torin
    Lugo-Fagundo, Maria F.
    Christine, Mei
    Sargi, Zoukaa
    Livingstone, Alan S.
    Pozo-Kaderman, Cristina
    Weed, Donald T.
    ANNALS OF SURGICAL ONCOLOGY, 2022, 29 (SUPPL 2) : 503 - 503
  • [34] cfHPV DNA as a marker of treatment results in patients with HPV-related head and neck cancer.
    Rutkowski, T.
    Mazurek, A.
    Snietura, M.
    Wygoda, A.
    Kentnowski, M.
    Polanowski, P.
    Dworzecka, U.
    Pilecki, B.
    Debiec, K.
    Gawron, I.
    Niedzialek, J.
    Piglowski, W.
    Bojko, U.
    Widlak, P.
    Skladowski, K.
    RADIOTHERAPY AND ONCOLOGY, 2017, 122 : 16 - 17
  • [35] Oncopolicy in high-income countries can make a difference in HPV-related Head and Neck Cancer
    Coughlan, D.
    O'Connor, T.
    Pai, S. I.
    Westra, W. H.
    Frick, K. D.
    O'Neill, C.
    Keogh, I. J.
    JOURNAL OF CANCER POLICY, 2013, 1 (3-4) : E49 - E51
  • [36] Lymph node density and response to induction TPF in patients with HPV-related head and neck cancer.
    Agbahiwe, H. C.
    Marur, S.
    Forastiere, A. A.
    Sanguineti, G.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [37] Management of HPV-Related Squamous Cell Carcinoma of the Head and Neck: Pitfalls and Caveat
    Perri, Francesco
    Longo, Francesco
    Caponigro, Francesco
    Sandomenico, Fabio
    Guida, Agostino
    Scarpati, Giuseppina Della Vittoria
    Ottaiano, Alessandro
    Muto, Paolo
    Ionna, Franco
    CANCERS, 2020, 12 (04)
  • [38] The role of miRNAs in human papilloma virus (HPV)-associated cancers: bridging between HPV-related head and neck cancer and cervical cancer
    C B Lajer
    E Garnæs
    L Friis-Hansen
    B Norrild
    M H Therkildsen
    M Glud
    M Rossing
    H Lajer
    D Svane
    L Skotte
    L Specht
    C Buchwald
    F C Nielsen
    British Journal of Cancer, 2012, 106 : 1526 - 1534
  • [39] Comprehensive analysis of mitophagy in HPV-related head and neck squamous cell carcinoma
    Li Yanan
    Liang Hui
    Cheng Zhuo
    Ding Longqing
    Sun Ran
    Scientific Reports, 13
  • [40] Sharing a diagnosis of HPV-related head and neck cancer: The emotions, the confusion, and what patients want to know
    Baxi, Shrujal S.
    Shuman, Andrew G.
    Corner, Geoffrey W.
    Shuk, Elyse
    Sherman, Eric J.
    Elkin, Elena B.
    Hay, Jennifer L.
    Pfister, David G.
    HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2013, 35 (11): : 1534 - 1541